Skip to content Search the desk⌘ Ctrl K Agent Sign in C Camp4 Therapeutics Corp
C CAMP Camp4 Therapeutics Corp
C CAMP Camp4 Therapeutics Corp
Earnings When Camp4 Therapeutics Corp reports, what it reported each quarter, and how the stock took the results.
15 quarters. Mar 31, 2023 to Sep 30, 2026. USD.
Next results · Q4 2026 Projected
No earnings release is on file for this company, so the day is the 10-K’s, projected from its last 2 filings.
Quarter Q4 2026 · Ends about Dec 31, 2026
10-K window Feb 26 – Apr 2 Quarter by quarter 3 years 5 years
Revenue Net income EPS Operating income Operating cash flow Free cash flow
Q3 2026 $ 1 . 9 0 M $1.90M +138.9% vs Q3 2025
Q3 2026 Nov 5, 2026, after the close
Revenue $1.90M +138.9%
Net income -$28.96M N/M
EPS -$0.37 N/M Camp4 Therapeutics Corp · CIK 1736730 · Engraved from SEC EDGAR
Revenue $1.78M +18.8%
Net income -$33.53M N/M
EPS -$0.58 N/M
Revenue $1.29M +50.8%
Net income -$18.33M N/M
EPS -$0.32 N/M Q4 2025 Mar 5, 2026, after the close9.2% by the close of Mar 6
Revenue $348.00K −46.6%
Net income -$40.28M N/M
EPS — —
Results day Typical move ±7.4% A typical move of 7.4% either way
Up after 4 of 9, down after 5.
−6.4% −15.1% −7.4%
When it reports
Usual day Thursday 6 of its last 7
After quarter end 37 to 52 days
10-Q filed 37 to 45 days over its last 7
10-K filed 64 to 86 days over its last 2 ended Sep 30, 2024 · filed Nov 21, 2024 · 52 d ended Dec 31, 2024 · filed Mar 27, 2025 · 86 d ended Mar 31, 2025 · filed May 13, 2025 · 43 d ended Jun 30, 2025 · filed Aug 14, 2025 · 45 d ended Sep 30, 2025 · filed Nov 6, 2025 · 37 d Q2 2026 Jun 30, 2026 Aug 13, 2026 · after-hours Aug 13, 2026 44 d 10-Q $1.78M +18.8% -$0.58 +20.9%
Q1 2026 Mar 31, 2026 May 7, 2026 · after-hours May 7, 2026 37 d 10-Q $1.29M +50.8% -$0.32 +3.6%
FY 2025 Q4 2025 derived Dec 31, 2025 — Mar 5, 2026 64 d 10-K $348.00K −46.6% — 9.2% Q3 2025 Sep 30, 2025 Nov 6, 2025 · after-hours Nov 6, 2025 37 d 10-Q $795.00K — -$0.55 4.3% Q2 2025 Jun 30, 2025 Aug 14, 2025 · after-hours Aug 14, 2025 45 d 10-Q $1.50M — -$0.62 +7.4% Q1 2025 Mar 31, 2025 May 13, 2025 · after-hours May 13, 2025 43 d 10-Q $858.00K — -$0.62 7.4%
FY 2024 Q4 2024 derived Dec 31, 2024 Mar 27, 2025 · after-hours Mar 27, 2025 86 d 10-K $652.00K — — 15.1% Q3 2024 Sep 30, 2024 Nov 21, 2024 · after-hours Nov 21, 2024 52 d 10-Q $0.00 −100.0% -$24.19 6.4% Q2 2024 Jun 30, 2024 — — — — $0.00 — -$26.00 — Q1 2024 Mar 31, 2024 — — — — $0.00 — -$26.57 —
Earlier years, FY 2023 to FY 2023 The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
10-Q
May 7, 2026
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
Year over year, last four quarters
Revenue $348.00K Revenue, change from a year earlier: Q3 2026 +138.9%, Q2 2026 +18.8%, Q1 2026 +50.8%, Q4 2025 −46.6% −46.6% +50.8% +18.8% +138.9%
Net income -$40.28M Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m n/m n/m n/m n/m
EPS — EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m n/m n/m n/m n/m +9.5% by the close of Nov 6
Thaler Research Engraved from SEC EDGAR © 2026 Thaler. All rights reserved. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
+20.9% by the close of Aug 14
ended Dec 31, 2025 · filed Mar 5, 2026 · 64 d ended Mar 31, 2026 · filed May 7, 2026 · 37 d ended Jun 30, 2026 · filed Aug 13, 2026 · 44 d ended Sep 30, 2026 · filed Nov 5, 2026 · 36 d window Feb 26 – Apr 2 · projected Few filings are on file, so the projected window is widened until the pattern is clear.
The stock’s move from the last close before each release to the first close after it, over the last 9 releases. Largest: +20.9% after Q2 2026.
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Provenance Data status and checks